oximeter

In late December 2023, Apple encountered a setback in the U.S. as certain Apple Watch models faced a sales suspension due to alleged patent infringement related to Masimo’s blood oxygen detection technology. The regulatory authorities will review Apple’s updated designs by mid-January 2024, and the potential financial and time costs associated with settlement or redesign have raised questions about the future of blood oxygen monitoring in Apple Watches. Apple‘s appeal for reinstatement is met with two potential routes.…

In mid-2021, medical technology company Masimo sued Apple over the Watch Series 6's blood oxygen monitoring capabilities. Masimo accused the tech giant of infringing on five of its pulse oximeter patents after introducing a device that has the ability to measure blood oxygen saturation. Now, a US International Trade Commission (ITC) judge has ruled that Apple did indeed infringe on one of Masimo's pulse oximeter patents.  While the judge has also concluded that the tech giant did not infringe on the other four patents…